F9H-61040-15648
5 vaccinations
6 coded responses
38 check-ins
6 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 342 / FL
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Dose 1 — Moderna
-
2021-01-22
Registered in v-safe
-
2021-01-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
- 2021-01-24
- 2021-01-26
- 2021-01-27
-
2021-01-30
Survey response — day 7, dose 1MedDRA: Fatigue, Injection site rash, Injection site warmth — Feeling: Fair · Site: Pain, Redness · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Rash appeared at injection site 7 days after injection accompanied by fatigue that resulted in 18 hours of sleep in 24 hours. Rash is very noticeably warm.warmMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Survey response — day 14, dose 1MedDRA: Fatigue, Injection site rash, Injection site warmth — Feeling: Good · Be unable to workFree text: On day 7 - 9 had warm red rash at injection site. Also experienced fatigue especially on day 7 - slept 18 hrs instead of usual 8.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Survey response — day 21, dose 1MedDRA: Fatigue, Injection site rash — Feeling: Good · Be unable to workFree text: Rash at injection site and fatigue days 7 - 9 post injection.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Dose 2 — Moderna
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-01
- 2021-03-22
- 2021-03-29
- 2021-05-17
-
2021-08-16
Survey response — 6 months, dose 2MedDRA: Abdominal pain, Diarrhoea, Fatigue, Oropharyngeal pain — Feeling: FairFree text: Diarrhea, fatigue mild sore throat and abdominal soreness.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-26
Dose 3 — Moderna
- 2021-10-27
- 2021-10-29
- 2021-10-31
- 2021-11-01
- 2021-11-04
- 2021-11-11
- 2021-11-23
- 2021-11-30
-
2022-04-16
Dose 4 — Moderna
- 2022-04-18
- 2022-04-21
- 2022-04-25
- 2022-04-30
- 2022-05-09
- 2022-05-16
- 2022-05-21
- 2022-05-28
- 2022-07-16
-
2022-09-21
Dose 5 — Moderna
-
2022-10-06
Survey response — day 14, dose 5MedDRA: Urinary tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Complicated UTIMedDRA releases: 2024-11 · check-in free text available
-
2022-10-06
Report sent to call center — day 14, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-10-07
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-21
- 2022-10-26
- 2022-11-02
-
2022-12-21
Survey response — 3 months, dose 5MedDRA: COVID-19, Hospitalisation, Intensive care — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Positive for COVID. Hospitalized for 8 days. In ICU for 3 days. · Healthcare visit (other): Hospital 8 days. ICU 3 DAYSMedDRA releases: 2024-11 · check-in free text available
-
2022-12-21
Report sent to call center — 3 months, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2022-12-22
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Moderna | |
| 2 | 2021-02-15 | Moderna | |
| 3 | 2021-10-26 | Moderna | No |
| 4 | 2022-04-16 | Moderna | No |
| 5 | 2022-09-21 | Moderna | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 1
Free text
Release 3 — day 7, dose 1
Systemic reaction (other): Rash appeared at injection site 7 days after injection accompanied by fatigue that resulted in 18 hours of sleep in 24 hours. Rash is very noticeably warm.warm
Release 3 — day 14, dose 1
Symptoms: On day 7 - 9 had warm red rash at injection site. Also experienced fatigue especially on day 7 - slept 18 hrs instead of usual 8.
Release 4 — day 21, dose 1
Symptoms: Rash at injection site and fatigue days 7 - 9 post injection.
Release 9 — 6 months, dose 2
Symptoms: Diarrhea, fatigue mild sore throat and abdominal soreness.
Release 12 — day 14, dose 5
Symptoms: Complicated UTI
Release 12 — 3 months, dose 5
Symptoms: Positive for COVID. Hospitalized for 8 days. In ICU for 3 days.
Healthcare visit (other): Hospital 8 days. ICU 3 DAYS
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Hospitalisation | · | · | ✓ |
| HCVO | Intensive care | · | · | ✓ |
| SD | Abdominal pain | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Intensive care | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Urinary tract infection | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site rash | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release